Loading...
UK Trademark — IPO
embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline
Application UK00002284563 · Registered
Quick Facts
| Application Number | UK00002284563 |
| Status | Registered |
| Owner | ViiV Healthcare UK Limited |
| Filed | 2001-11-01 |
| Registered | 2002-11-22 |
| Renewal Due | 2031-11-01 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Is this trademark active?
Yes. embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline is currently a registered UK trademark, with renewal due on 2031-11-01. It is protected under UK intellectual property law and can be enforced against infringing uses.
Mark Details (as filed at the IPO)
Mark description / limitation
The applicant claims the colours green, yellow, red and purple as an element of the first mark in the series.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations and substances for use in the treatment and/or alleviation of AIDS and/or HIV; anti-viral pharmaceutical preparations and substances.
Class 41 — Education & Entertainment
Educational and training services; organisation of training including organisation of classes, seminars, conferences, symposiums and workshops; publication of texts and supply of educational material; all of the aforesaid services relating to AIDS/HIV issues and to raising the awareness and understanding of AIDS/HIV issues.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 02.07.25 — Human beings
Timeline
- Filed: 2001-11-01
- First published: 2002-08-07 (Journal 6442)
- Registered: 2002-11-22
- Renewal due: 2031-11-01
About This Trademark
'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' is a registered trademark on the UK IPO register, owned by ViiV Healthcare UK Limited. The application (UK00002284563) was filed on 1 November 2001 and registered on 22 November 2002. The registration is set to expire on 1 November 2031.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services), specifically covering: The applicant claims the colours green, yellow, red and purple as an element of the first mark in the series.
The trademark is represented by Legal Brand Protection.
Frequently Asked Questions
Who owns UK trademark UK00002284563 ('embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline')?
UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' in Class 5, 41 is recorded on the UK IPO register as owned by ViiV Healthcare UK Limited. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00002284563 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' as registered.
Which Nice classes is UK trademark UK00002284563 registered under?
UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services). The filed specification reads: Class 5: Pharmaceutical preparations and substances for use in the treatment and/or alleviation of AIDS and/or HIV; anti-viral pharmaceutical preparations and substances. | Class 41: Educational and training services; organisation of training including organisation of classes, seminars, conferences, symposiums and w…
When was UK trademark UK00002284563 filed?
UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' was filed at the UK IPO on 1 November 2001 and registered on 22 November 2002.
When was UK trademark UK00002284563 published?
The UK IPO first published / advertised UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' on 7 August 2002.
When does UK trademark UK00002284563 need to be renewed?
UK trademark UK00002284563 for the mark 'embrace inabata . tegeera . embrasser . kulikabili . gumbatana . bambanani Embrace is an HIV health promotion programme for African people living in the UK from GlaxoSmithKline' is currently recorded as valid until 1 November 2031, at which point it will need to be renewed with the UK IPO to remain in force.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.